# Protara Therapeutics, Inc.: Form 8-K, filed May 8, 2025

- Company: [Protara Therapeutics, Inc.](/companies/tara.md) (CIK 1359931)
- Form: 8-K
- Filed: 2025-05-08
- Accepted by EDGAR: May 8, 2025, 08:05 ET
- Period: 2025-05-08
- Accession: 0001213900-25-040809
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1359931/000121390025040809/ea0240929-8k_protara.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1359931/000121390025040809/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1359931/000121390025040809/ea0240929-8k_protara.htm

Filed May 8, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-040809. Last ingested by Listed: Oct 24, 2026, 15:11 ET. No prices; not investment advice.